BioCardia Files 8-K
Ticker: BCDA · Form: 8-K · Filed: Jul 24, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Jul 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
TL;DR
BioCardia filed an 8-K on 7/24/25. Check for updates.
AI Summary
BioCardia, Inc. filed an 8-K on July 24, 2025, reporting other events and financial statements. The company, formerly known as Tiger X Medical, Inc., is incorporated in Delaware and headquartered in Sunnyvale, California.
Why It Matters
This filing indicates BioCardia, Inc. is making a regulatory submission to the SEC, which could contain important updates on the company's operations or financial status.
Risk Assessment
Risk Level: low — This is a routine SEC filing (8-K) that typically reports significant events, but the filing itself does not inherently present new risks.
Key Numbers
- 001-38999 — SEC File Number (Identifies the company's filing with the SEC.)
- 23-2753988 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- Tiger X Medical, Inc. (company) — Former company name
- July 24, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Sunnyvale, California (location) — Principal executive offices
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items being reported, but the specific details of these events are not provided in the excerpt.
When was BioCardia, Inc. previously known by another name?
BioCardia, Inc. was formerly known as Tiger X Medical, Inc., with a name change date of June 16, 2011.
Where are BioCardia, Inc.'s principal executive offices located?
The principal executive offices of BioCardia, Inc. are located at 320 Soquel Way, Sunnyvale, California 94085.
What is the SIC code for BioCardia, Inc.?
The Standard Industrial Classification (SIC) code for BioCardia, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the fiscal year end for BioCardia, Inc.?
The fiscal year end for BioCardia, Inc. is December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 24, 2025 regarding BioCardia, Inc. (BCDA).